A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants

Keyphrases

• Multiplexing 100%
• Mass Spectrometry 100%
• COVID-19 100%
• Whole Genome Sequencing 100%
• Diagnostic Sensitivity 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 Variants 100%
• Colombia 50%
• Health Systems 50%
• Comprehensive Evaluation 50%
• Patient Care 50%
• Molecular Variants 50%
• Infection Prevention 50%
• Diagnostic Performance 50%
• Preventive Care 50%
• Variant Calling 50%
• New York City 50%
• Transmissibility 50%
• MassARRAY 50%
• Omicron BA.1 50%
• Omicron BA.2 50%
• Variant Identification 50%
• Inter-rater Agreement 50%
• Diagnostic Panel 50%
• Multiplexed Diagnostics 50%
• Target Pattern 50%

Biochemistry, Genetics and Molecular Biology

• SARS Coronavirus 100%
• Mass Spectrometry 100%
• Whole Genome Sequencing 66%
• RNA 33%

Pharmacology, Toxicology and Pharmaceutical Science

• SARS Coronavirus 100%
• Infection 33%